LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Moderna Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

24.82 5.08

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

23.64

Max

25.43

Pagrindiniai rodikliai

By Trading Economics

Pajamos

149M

-971M

Pardavimai

-859M

107M

P/E

Sektoriaus vid.

35.86

56.602

Pelnas, tenkantis vienai akcijai

-2.52

Pelno marža

-907.477

Darbuotojai

5,800

EBITDA

194M

-924M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+95.73% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-31

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-2.7B

9.9B

Ankstesnė atidarymo kaina

19.74

Ankstesnė uždarymo kaina

24.82

Naujienos nuotaikos

By Acuity

100%

0%

371 / 382 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Moderna Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-03-31 14:19; UTC

Pagrindinės rinkos jėgos

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

2025-02-04 18:52; UTC

Pagrindinės rinkos jėgos

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

2024-11-15 10:28; UTC

Pagrindinės rinkos jėgos

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

2025-05-12 22:14; UTC

Svarbiausios naujienos

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

2025-05-12 18:45; UTC

Svarbiausios naujienos

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- Update

2025-05-12 17:14; UTC

Svarbiausios naujienos

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- WSJ

2025-04-28 17:04; UTC

Uždarbis

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

2025-02-28 12:00; UTC

Svarbiausios naujienos

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

2025-02-24 10:17; UTC

Karštos akcijos

Stocks to Watch Monday: Domino's, Berkshire Hathaway; Alibaba -- WSJ

2025-02-14 22:04; UTC

Uždarbis

These Stocks Moved the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

2025-02-14 20:26; UTC

Uždarbis

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

2025-02-14 17:34; UTC

Uždarbis

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

2025-02-14 15:42; UTC

Uždarbis

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DraftKings, GameStop, and More -- Barrons.com

2025-02-14 14:02; UTC

Svarbiausios naujienos
Uždarbis

Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker. -- Barrons.com

2025-02-14 11:38; UTC

Svarbiausios naujienos
Uždarbis

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

2025-02-14 11:34; UTC

Uždarbis

These Stocks Are Moving the Most Today: Intel, Airbnb, DraftKings, GameStop, Moderna, Roku, Palo Alto, and More -- Barrons.com

2025-02-14 11:30; UTC

Svarbiausios naujienos
Uždarbis

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

2025-02-04 19:34; UTC

Svarbiausios naujienos

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

2025-02-04 18:51; UTC

Svarbiausios naujienos

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

2025-01-21 10:12; UTC

Karštos akcijos

Stocks to Watch Tuesday: MicroStrategy, Trump Media, Moderna, Ørsted -- WSJ

2025-01-13 13:51; UTC

Uždarbis

Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast. -- Barrons.com

2025-01-08 09:43; UTC

Karštos akcijos

Stocks to Watch Wednesday: Moderna, Nvidia, Albertsons, Flutter -- WSJ

2024-11-15 19:24; UTC

Uždarbis

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More -- Barrons.com

2024-11-15 17:23; UTC

Uždarbis

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More -- Barrons.com

2024-11-15 15:43; UTC

Uždarbis

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Alibaba, Bloom Energy, and More -- Barrons.com

2024-11-15 13:34; UTC

Svarbiausios naujienos

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

2024-11-15 13:08; UTC

Svarbiausios naujienos

Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

2024-11-15 11:14; UTC

Rinkos pokalbiai

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

2024-11-15 10:34; UTC

Rinkos pokalbiai

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

2024-11-07 11:53; UTC

Svarbiausios naujienos
Uždarbis

Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Moderna Inc Prognozė

Kainos tikslas

By TipRanks

95.73% į viršų

12 mėnesių prognozė

Vidutinis 46.29 USD  95.73%

Aukščiausias 212 USD

Žemiausias 21 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Moderna Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

19 ratings

4

Pirkti

12

Laikyti

3

Parduoti

Techninis įvertinimas

By Trading Central

23.7 / 27.88Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

371 / 382 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.